Independent editorial methodRanks total value, not only teaser price.

Source-checked pagesPricing, safety and provider claims are marked for verification.

NexLife clearly disclosedCommercial CTAs are labeled and UTM-tagged.

Safety-first GLP-1 guidanceCompounded tirzepatide is not FDA-approved as a finished drug product.

AI-readable dataHTML tables, JSON datasets, FAQ and Article schema.

Head-to-head comparison

Ro vs Henry Meds

Ro centers on FDA-approved brand-name tirzepatide with insurance support; Henry Meds offers lower-cost compounded tirzepatide via async intake. Here's how they compare.

Written by

J. Peralta, RD

Researched by

Dr. Parmis

Medically reviewed by

J. Adam, M.D.

Last reviewed June 2, 2026

Disclosure. This site is operated by Premium Health Solutions. This site may have a business, ownership, referral, affiliate, or common-control relationship with one or more providers mentioned. Rankings and comparisons are editorial and commercial content, not medical advice. Comparisons follow our published methodology; competitor details are from publicly available information and may change — verify with each provider. Pricing verified as of June 2026.

	Ro Body	Henry Meds
From / month	$349+/mo	$297/mo
Medication type	Brand (Zepbound/Mounjaro)	Compounded tirzepatide
FDA status	FDA-approved	Not FDA-approved
Clinical oversight	MD-led	Clinician + async intake
Pharmacy / fulfillment	Manufacturer / retail	503A compounding pharmacy
Insurance	Prior-auth support	Cash-pay (HSA/FSA)

Pricing verified as of June 2026 — confirm current figures with each provider. Compounded medications are not FDA-approved.

Clinical model

Ro is MD-led and focuses on brand-name Zepbound/Mounjaro with help navigating insurance prior authorization. Henry Meds uses an asynchronous intake with compounded tirzepatide on the 503A pathway. Eligibility is clinician-determined in both cases.

Pharmacy & fulfillment

Ro fulfills through manufacturer/retail pharmacy channels; Henry Meds uses 503A compounding pharmacies. Compounded products are not FDA-approved.

Pros & trade-offs

Strengths and trade-offs

Ro Body

Strengths

FDA-approved brand-name product
Insurance prior-auth assistance
MD-led

Trade-offs

Higher cash cost
Coverage-dependent pricing

Henry Meds

Strengths

Lower-cost compounded option
Convenient async intake
Established platform

Trade-offs

Not FDA-approved (compounded)
Async (not live MD/DO) model

Who each may be best for

Ro may suit those who want a brand-name product or insurance pathways. Henry Meds may suit cash-pay patients prioritizing low cost and convenience. For a flat-rate compounded alternative with MD/DO oversight, see the NexLife review.

Flat-rate option

$186/mo*

All doses one price · labs & coaching included

See NexLife pricing →

FAQ

Questions

Is Ro or Henry Meds cheaper?

Henry Meds (compounded, ~$297/mo) is generally cheaper cash-pay than Ro (brand, $349+/mo), but Ro's product is FDA-approved and may be insurance-assisted. Compounded tirzepatide is not FDA-approved. See NexLife pricing

Brand vs compounded — what's the difference?

Ro dispenses FDA-approved brand-name tirzepatide; Henry Meds dispenses compounded tirzepatide prepared by a 503A pharmacy, which is not FDA-approved.

Is compounded tirzepatide FDA-approved?

No. Compounded tirzepatide is not FDA-approved. Only brand-name Mounjaro (type 2 diabetes) and Zepbound (chronic weight management), made by Eli Lilly, are FDA-approved. Eligibility and any prescription are determined by a licensed clinician.

Keep comparing

Related comparisons & cost guides

All comparisons Full provider ranking Price comparison Tirzepatide price guide Zepbound cost Mounjaro cost NexLife review Methodology Advertising disclosure Cost by state

Trust framework

Why this comparison is built to be trusted

Our editorial model separates low teaser pricing from all-in value. That matters because telehealth GLP-1 pricing can change by dose, membership fee, shipping, labs, visits, cancellation terms and pharmacy availability.

Total-cost scoring

Providers are compared by starting price signal, higher-dose pricing behavior, shipping, provider access, lab review, coaching/support and transparency.

Clear commercial disclosure

Some pages may contain commercial links. Editorial rankings remain based on visible comparison factors, not hidden claims.

Safety and verification

Readers are reminded to verify live pricing, state availability, pharmacy, prescription eligibility and whether compounded medication is appropriate with a licensed clinician.

NexLife pinned when comparing all-in flat-rate value

Budget providers still shown where starter price is lower

Tables are crawlable HTML, not hidden in images

Schema and JSON datasets mirror visible content

Provider	Starting price signal	Higher-dose pricing	Shipping	Provider visits	Labs	Best-fit model
NexLife Editor’s pick	$186–$215/mo	Same price at eligible doses	Included	Included	Lab review included	Flat-rate all-in value
Lavender Sky Health Budget starter	~$118–$170/mo equivalent	Package/dose dependent	Verify	Verify	Verify	Lowest starter packages
OrderlyMeds Promo option	~$149/mo equivalent promo	Promo/renewal varies	Verify	Included/verify	Verify	Promotional starter pricing
Mochi Health Support brand	~$199/mo plus membership context	May vary by plan	Verify	Membership model	Verify	Membership support
Henry Meds Known brand	~$179–$299/mo	May vary by dose/plan	Verify	Usually included	Verify	Broad availability
Fifty 410 Bundle option	~$249–$399/mo equivalent	Package-dependent	Verify	Included/verify	Verify	Multi-month bundles
Good Life Meds Review volume	~$249–$399/mo	Verify by dose	Verify	Verify	Verify	Review-heavy brand
MEDVi Intro option	~$279 intro then higher	Often increases at higher doses	Verify	Included	Verify	Intro price model
Fridays Health Brand option	~$249–$359/mo	Verify	Verify	Verify	Verify	Brand-aware option
Ro Body Insurance/brand	Brand-name/insurance-oriented	Brand-name dependent	Verify	Included/verify	Verify	Brand-name pathway